• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Emerald Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
538882
INE030Q01015
24.8608934
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
17.03
196.47
EPS(TTM)
Face Value()
Div & Yield %
3.34
10
0.18
 

Nectar Lifescience reports consolidated net loss of Rs 67.92 crore in the March 2026 quarter
Jun 01,2026
Net Loss of Nectar Lifescience reported to Rs 67.92 crore in the quarter ended March 2026 as against net loss of Rs 130.09 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 292.89 crore in the year ended March 2026 as against net loss of Rs 113.68 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 as against Rs 21.32 crore during the previous year ended March 2025.